Balanced Growth in the Structural Dynamic Economic Model SDEM-2

2014 ◽  
Vol 3 (3) ◽  
pp. 237-253
Author(s):  
Dmitry V. Kovalevsky
Keyword(s):  
Economic Model ◽  
Structural Dynamic ◽  
Balanced Growth ◽  
Dynamic Economic Model

A tourism growth model

2019 ◽  
Vol 26 (5) ◽  
pp. 746-763 ◽  
Author(s):  
Federico Inchausti-Sintes
Keyword(s):  
Economic Growth ◽  
Economic Model ◽  
Industrial Sector ◽  
Cge Model ◽  
Economic Progress ◽  
Secondary Sector ◽  
Dynamic Cge ◽  
Productivity Gains ◽  
Dynamic Economic Model

Two processes can be used to summarize the productive-mix of a tourism-led economy: the lack of a significant secondary sector and strong tertiarization. Both developments have had significant consequences for productivity gains that, as shown by empirical research, are key to understanding economic progress. In fact, this productivity has been predominantly concentrated in the industrial sector while services have relied more on factor accumulation. However, this varying economic pattern has permitted long-lasting economic growth in current tourism-led economies. This article develops a theoretical dynamic economic model (a dynamic CGE model) to explain the beginning, development and long-term growth consequences of tourism-led economies.

scholarly journals Bioprospecting and biodiversity contracts

2003 ◽  
Vol 8 (3) ◽  
pp. 417-435 ◽  
Author(s):  
Denise M. Mulholland ◽  
Elizabeth A. Wilman
Keyword(s):  
Drug Discovery ◽  
Property Rights ◽  
Pharmaceutical Company ◽  
Host Country ◽  
Economic Model ◽  
Genetic Information ◽  
Discovery Process ◽  
Drug Discovery Process ◽  
High Quality ◽  
Dynamic Economic Model

A dynamic economic model for a biodiversity prospecting contract, between a host country and a pharmaceutical company, is developed and used to explain the structure of existing contracts. The host country's stocks of biodiversity and genetic information are crucial inputs to the production of high-quality samples. Even with compete property rights contracts will be second best; it is not possible to perfectly monitor host-country inputs to the drug discovery process. Contracts vary due to the different degrees of observability of host-country inputs, and incomplete or ineffective property rights.

Sign in / Sign up

Export Citation Format

Share Document